Virtu Financial LLC acquired a new stake in shares of NeueHealth, Inc. (NYSE:NEUE – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund acquired 10,232 shares of the company’s stock, valued at approximately $76,000. Virtu Financial LLC owned 0.12% of NeueHealth as of its most recent filing with the SEC.
Analyst Ratings Changes
Separately, Royal Bank of Canada reduced their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.
Read Our Latest Report on NeueHealth
NeueHealth Price Performance
NeueHealth (NYSE:NEUE – Get Free Report) last posted its quarterly earnings data on Thursday, March 20th. The company reported ($7.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.29) by ($5.12). NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. The business had revenue of $232.64 million for the quarter, compared to the consensus estimate of $261.80 million. On average, research analysts anticipate that NeueHealth, Inc. will post -9.13 EPS for the current year.
Insider Buying and Selling
In other NeueHealth news, CEO George Lawrence Mikan III sold 12,440 shares of the business’s stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $6.13, for a total value of $76,257.20. Following the completion of the sale, the chief executive officer now owns 249,454 shares in the company, valued at approximately $1,529,153.02. The trade was a 4.75 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Jay Matushak sold 4,970 shares of NeueHealth stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the transaction, the chief financial officer now directly owns 17,747 shares in the company, valued at approximately $130,085.51. The trade was a 21.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 110,033 shares of company stock worth $774,560. Insiders own 64.30% of the company’s stock.
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Recommended Stories
- Five stocks we like better than NeueHealth
- The How And Why of Investing in Oil Stocks
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Top Stocks Investing in 5G Technology
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- How to Choose Top Rated Stocks
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding NEUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NeueHealth, Inc. (NYSE:NEUE – Free Report).
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.